Che Guowei, Zhi Xiuyi
Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.
Department of Thoracic Surgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.
Zhongguo Fei Ai Za Zhi. 2014 Dec;17(12):884-8. doi: 10.3779/j.issn.1009-3419.2014.12.11.
The close association between chronic obstructive pulmonary disease (COPD) and lung cancer has long been known. New evidence suggests that there is an inverse relationship between the severity of pulmonary function and the risk of surgery in patients with lung cancer, COPD may play a key role in the incidence of postoperative pulmonary complications (PPC) and improving pulmonary function with perioperation airway management has been suggested as a possible preventive PPC. This review describes the current understanding and clinical application of perioperation airway management in lung cancer patients with COPD. We summarized that: (1) The necessity of perioperation airway management; (2) The status and characteristic of inhaled drug in perioperation airway management; (3) The clinical value in improving pulmonary function of perioperation airway management; (4) The optimum population of peri-operation airway management; (5) The problem of perioperation airway management.
慢性阻塞性肺疾病(COPD)与肺癌之间的密切关联早已为人所知。新证据表明,肺癌患者的肺功能严重程度与手术风险呈负相关,COPD可能在术后肺部并发症(PPC)的发生中起关键作用,有人提出通过围手术期气道管理改善肺功能可能是预防PPC的一种方法。本综述描述了目前对合并COPD的肺癌患者围手术期气道管理的认识及临床应用。我们总结如下:(1)围手术期气道管理的必要性;(2)吸入药物在围手术期气道管理中的地位和特点;(3)围手术期气道管理在改善肺功能方面的临床价值;(4)围手术期气道管理的最佳人群;(5)围手术期气道管理的问题。